Ginevra Martelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ginevra Martelli has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Francesca Bruni
Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
4 shared publications - Luca Rapparini
Dermatology Unit IRCCS Azienda Ospedaliero‐Universitaria di Bologna Bologna Italy
4 shared publications - Michela Starace
Dermatology Unit IRCCS Azienda Ospedaliero‐Universitaria di Bologna Bologna Italy
4 shared publications - Stephano Cedirian
Dermatology Unit IRCCS Azienda Ospedaliero‐Universitaria di Bologna Bologna Italy
4 shared publications - Francesca Pampaloni
Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
3 shared publications Bianca Maria Piraccini
Private Dermatology Practice Bologna Italy
2 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by Springer Nature in Dermatology and Therapy
- Vol. 16 (11) , 5855-5862
Topical Delgocitinib for Capecitabine-Induced Hand–Foot Syndrome: A Therapeutic Option?
- 7 October 2026
- Published by Springer Nature in Dermatology and Therapy
- Vol. 16 (11) , 5855-5862
Open AccessTopical Delgocitinib for Capecitabine-Induced Hand–Foot Syndrome: A Therapeutic Option?
- Open Access
- 3 September 2025
- Published by Springer Nature in Dermatology and Therapy
- Vol. 15 (11) , 3419-3424
Efficacy of Skin Patting and Iontophoresis with Dutasteride Gel in Male and Menopausal Female Androgenetic Alopecia: A Pilot Study
Introduction Androgenetic alopecia (AGA) is a chronic, progressive condition often resistant to conventional treatments. Transdermal delivery systems such as iontophoresis and skin patting (SPi) may enhance drug penetration and follicular targeting. Dutasteride, a potent dual 5α-reductase inhibitor, has shown superior efficacy to finasteride, but topical delivery is limited by variable absorption. In this pilot study, we evaluated the efficacy and safety of dutasteride gel delivered via SPi and iontophoresis in men and postmenopausal women with treatment-resistant AGA. Methods In this single-center pilot study, 20 adults (10 males, 10 postmenopausal females) with AGA unresponsive to ≥ 12 months of standard therapy underwent four monthly sessions of SPi and iontophoresis with 6% dutasteride gel. Hair density, shaft diameter, and pull test results were assessed at baseline and 8 weeks post-treatment; patient satisfaction (0–4 scale) and safety were recorded. Paired tests were used to analyze the results, with p < 0.05 considered to indicate significance. Results Hair density improved significantly in frontal (p < 0.001) and vertex (p < 0.001) regions. Shaft diameter increased in vertex (p < 0.001) and frontal areas (p = 0.046). Pull test scores improved (p < 0.001). Mean satisfaction was 3.4/4. No adverse events occurred. Conclusion SPi with iontophoresis effectively delivered topical dutasteride, yielding significant clinical improvement and excellent safety in treatment-resistant AGA. Larger randomized trials are warranted to confirm these findings.
- 3 September 2025
- Published by Springer Nature in Dermatology and Therapy
- Vol. 15 (11) , 3419-3424
Open AccessEfficacy of Skin Patting and Iontophoresis with Dutasteride Gel in Male and Menopausal Female Androgenetic Alopecia: A Pilot Study
Introduction Androgenetic alopecia (AGA) is a chronic, progressive condition often resistant to conventional treatments. Transdermal delivery systems such as iontophoresis and skin patting (SPi) may enhance drug penetration and follicular targeting. Dutasteride, a potent dual 5α-reductase inhibitor, has shown superior efficacy to finasteride, but topical delivery is limited by variable absorption. In this pilot study, we evaluated the efficacy and safety of dutasteride gel delivered via SPi and iontophoresis in men and postmenopausal women with treatment-resistant AGA. Methods In this single-center pilot study, 20 adults (10 males, 10 postmenopausal females) with AGA unresponsive to ≥ 12 months of standard therapy underwent four monthly sessions of SPi and iontophoresis with 6% dutasteride gel. Hair density, shaft diameter, and pull test results were assessed at baseline and 8 weeks post-treatment; patient satisfaction (0–4 scale) and safety were recorded. Paired tests were used to analyze the results, with p < 0.05 considered to indicate significance. Results Hair density improved significantly in frontal (p < 0.001) and vertex (p < 0.001) regions. Shaft diameter increased in vertex (p < 0.001) and frontal areas (p = 0.046). Pull test scores improved (p < 0.001). Mean satisfaction was 3.4/4. No adverse events occurred. Conclusion SPi with iontophoresis effectively delivered topical dutasteride, yielding significant clinical improvement and excellent safety in treatment-resistant AGA. Larger randomized trials are warranted to confirm these findings.